Montalban X, et al. Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients With Primary Progressive Multiple Sclerosis in the ORATORIO Trial. PR2086. EAN 2017.
Congres in teken van voortgang in onderzoek naar frontotemporale dementie
nov 2024 | Dementie